Opioid maker agrees to stop in-person marketing to doctors

Massachusetts

BOSTON (AP) — A Massachusetts pharmaceutical company accused of misleading doctors about the risks of its opioid product has agreed to pay $185,000 and will stop marketing to prescribers in-person.

Collegium Pharmaceutical agreed to the settlement Thursday after state Attorney General Maura Healey’s office found that the company marketed its Xtampza product as a safe an responsible alternative to other opioids, even though it has the same active ingredient as Oxycontin and other opioids.

Collegium also will be required to publicly disclose information about the doses of its opioids that are sold each quarter.

The company did not immediately respond to a request for comment.

Copyright 2022 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Providence

PINPOINT WEATHER // Quick Links:

Dan Yorke State of Mind

DYSOM 1/21/2: Joe Cammarano, Political Science Professor, Providence College

More Dan Yorke State of Mind

Don't Miss

LIVE CAMS on WPRI.com

More Live Cams
Viewer Pa on WPRI.com

Community Events & Happenings

More Community